相关实验视频

Updated: Jul 12, 2025

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

上调的细胞骨蛋白促进莫亚莫亚病的病理性血管生成

Shihao He^1,2,3, Junze Zhang¹, Ziqi Liu¹

¹Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China (S.H., J.Z., Z.L., Y.W., X.H., X.W., Z.Z., X.Y., Yahui Zhao, Yuanli Zhao, R.W.).

|October 27, 2023

概括

这项研究确定了莫亚莫亚病 (MMD) 患者中菲拉明A (FLNA) 和齐辛 (ZYX) 蛋白质的升高. 这些蛋白质有助于大脑血管内皮增生和MMD病原体.

科学领域:

蛋白质组学是指蛋白质组学.
血管生物学血管生物学
分子医学是分子医学.

背景情况:

莫亚莫亚病 (MMD) 是一种罕见的,进展性脑血管疾病,其特征是缩和内动脉封闭.
目前尚不完全了解MMD的潜在病原体.
识别关键的分子参与者对于理解MMD发展至关重要.

研究的目的:

为了研究异常表达的蛋白质在莫亚莫亚病的发病过程中的作用.
为了确定MMD诊断和治疗的潜在蛋白质生物标志物.

主要方法:

利用了来自60名MMD患者和20名健康对照者的血清上的数据独立采集质谱.
使用酶相关免疫吸收试验 (ELISA) 验证的差异表达蛋白质.
在血管样本上进行免疫光和体外内皮细胞实验以阐明机制.

主要成果:

量化了1555种蛋白质,在MMD血清中发现了显著升高的菲拉胺A (FLNA) 和紫辛 (ZYX) 水平.
免疫光检测证实了MMD血管样本中的亲密增生.
通过AKT/GSK-3β/β-catenin通路,FLNA和ZYX促进了内皮细胞的增殖,血管生成和细胞骨的变化.

结论:

这项大规模的蛋白质组学研究强调FLNA和ZYX在MMD中显著上调.
这些蛋白质与MMD特征的脑血管内皮增生有关.
研究结果表明,FLNA和ZYX对莫亚莫亚病具有诊断和治疗潜力.

关键词:

卡特尼尼是指一个连锁的物质.菲拉胺是一种纤维.酸是一种酸.样本的大小样本大小辛辛Zyxin是什么意思

更多相关视频

In Vitro Model of Coronary Angiogenesis

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...